The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.
Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.
Some of the most interesting moments in music production come when an arrangement won’t work. The groove is there and the melody is promising, but something
Process model forecasting (PMF) aims to predict the process model that will characterize a future period, thereby providing a process-level view of how behavior is expected to evolve. Existing PMF methods, however, forecast directly-follows graphs, which cannot explicitly…
Humanoid robots can acquire complex skills by imitating kinematic humanoid motion references, yet reliable references for contact-rich interactions remain difficult to obtain: motion capture deteriorates under occlusion and close physical contact, while retargeting introduces…
Insertion is a fundamental operation in robotic construction assembly, where variations in material properties and assembly conditions make it difficult to select contact forces that complete the task without exceeding the assembly's capacity. Although construction documents…
We argue here that the current dominant practice in LLM human simulation: prompting instruction-tuned assistant language models to role-play personas, is inaccurate and produces stereotyped predictions (lacking natural diversity). It has previously been shown that LLMs can be…